Dow closing down 31 points. Nasdaq droroing 0. 5 . This morning we learned in a total blockbuster of a deal. That pfizer is trying to reinvent itself by buying allergan, agn, to be more efficient with overseas capital. Allergan gives them a way to do that. It cost them a pretty penny, the company is confident this is a good one. Allergan has an excellent vaccine and cancer franchises, includudg their benchmark drug, botox, which they havent raised the price up, while simultaneously keeping up with new uses for the darn thing, past wrinkles and migraines. Perhaps they can run into a new form of company with this merger and the cash flow they had. Thats what the hope is. In the meaeaime youre being paid to wave dividends that nets 3. 5 . The market doesnt like this. Absolutely doesnt like this deal. For real allergan shareholders because its delighted with phaser before it closes. And potential government challenge over the tax avoidance scheme. We believed in Brett Saunders aspirational
Botox, which they havent raised the price up, while simultaneously keeping up with new uses for the darn thing, past wrinkles and migraines. Perhaps they can run into a new form of company with this merger and the cash flow they had. Thats what the hope is. In the meantime youre being paid to wave dividends that nets 3. 5 . The market doesnt like this. Absolutely doesnt like this deal. For real allergan shareholders because its delighted with phaser before it closes. And potential government challenge over the tax avoidance scheme. We believed in Brett Saunders aspirational earnings estimate. The ceo laid that over and over again, including on mad money. Thats something that frankly is no longer a factor. I still believe in Brent Saunders. Still believe in allergan money, more convoluted. The cut and run crowd and arbitrators will think otherwise, but totally understand the frustration of allergan shareholders who were really pretty furious, come to think of it. But pfizer is bag aller
Nasdaq dropping 0. 5 . This morning we learned in a total blockbuster of a deal. That pfizer is trying to reinvent itself by buying allergan, agn, to be more efficient with overseas capital. Allergan gives them a way to do that. It cost them a pretty penny, the company is confident this is a good one. Allergan has an excellent vaccine and cancer franchises, including their benchmark drug, botox, which they havent raised the price up, while simultaneously keeping up with new uses for the darn thing, past wrinkles and migraines. Perhaps they can run into a new form of company with this merger thats what the hope is. In the meantime youre being paid to wave dividends that nets 3. 5 . The market doesnt like this. Absolutely doesnt like this deal. For real allergan shareholders because its delighted with phaser before it closes. And potential government challenge over the tax avoidance scheme. We believed in Brett Saunders aspirational earnings estimate. The ceo laid that over and over agai